Zanubrutinib May Improve Response Rate Compared With Ibrutinib in Waldenström Macroglobulinemia
Researchers sough to determine whether zanubrutinib would improve responses compared with ibrutinib in patients with Waldenström macroglobulinemia.
Diagnosis & Disease Information
CD7 CAR-T Therapy Induced Remission in R/R T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Preliminary results of a clinical trial investigating the efficacy of CAR-T therapy in pediatric patients with CD7+ ALL/lymphoma were presented at ASCO 2022.
Trastuzumab Deruxtecan Deemed “Practice-Changing” for HER2-Low Metastatic Breast Cancer
Trastuzumab deruxtecan improved progression-free and overall survival, compared with physician’s choice of therapy.
The Effect of Gender Bias in Surveys of Patients With Myeloproliferative Neoplasm
Gender balance in cancer surveys was found to have relatively little effect on survey outcomes, according to results of a study presented at the 2022 ASCO Annual Meeting. Surveying patients with myeloproliferative neoplasms (MPN) has given valuable insight into polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) subtypes. However, independent surveys have included a…
Data Reveal Disparities in Telemedicine Use Among Patients With Cancer
Researchers found that socioeconomic status, insurance, race, and rurality were all associated with telemedicine use.
High-Dose Ifosfamide Bests Topotecan-Cyclophosphamide in Relapsed/Refractory Ewing Sarcoma
Ifosfamide improved event-free and overall survival.
Lack of Access, Not Lack of Interest, Prevents Black Patients From Enrolling in Clinical Trials
More than 80% of Black survey respondents said they were somewhat or very likely to consider enrolling in a clinical trial.
Increasing Public Welfare Spending Can Improve Survival for Black Cancer Patients
A 10% increase in public welfare spending was associated with an 8.6% improvement in 5-year overall survival for Black patients with cancer.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...